Hepatitis B virus reactivation and role of antiviral prophylaxis in lymphoma patients with past hepatitis B virus infection who are receiving chemoimmunotherapy.
about
KASL clinical practice guidelines: management of chronic hepatitis BClinical impact of occult hepatitis B virus infection in immunosuppressed patientsHepatitis B surface antigen seroconversion after HBV reactivation in non-Hodgkin's lymphoma.Effect of Antiviral Prophylaxis Strategy for Chemotherapy-Associated Hepatitis B Reactivation in Non-Hodgkin's Lymphoma Patients with Hepatitis B Virus Infection: A Retrospective Cohort Study.Cost Effectiveness of Universal Hepatitis B Virus Screening in Patients Beginning Chemotherapy for Sarcomas or GI Stromal Tumors.Chemotherapy-related reactivation of hepatitis B infection: updates in 2013.Current hepatitis B screening practices and clinical experience of reactivation in patients undergoing chemotherapy for solid tumors: a nationwide survey of medical oncologists.Risk factors for hepatitis B virus reactivation after conformal radiotherapy in patients with hepatocellular carcinoma.Management of the HBV reactivation in isolated HBcAb positive patients affected with Non Hodgkin Lymphoma.Chronic hepatitis virus infection in patients with multiple myeloma: clinical characteristics and outcomes.Risk of Severe Acute Exacerbation of Chronic HBV Infection Cancer Patients Who Underwent Chemotherapy and Did Not Receive Anti-Viral ProphylaxisSystematic review with network meta-analysis: Comparative efficacy of oral nucleos(t)ide analogues for the prevention of chemotherapy-induced hepatitis B virus reactivation.Hepatitis B virus reactivation and hepatitis in diffuse large B-cell lymphoma patients with resolved hepatitis B receiving rituximab-containing chemotherapy: risk factors and survival.KASL Clinical Practice Guidelines: Management of chronic hepatitis B.Rituximab-based treatment, HCV replication, and hepatic flares.Management of hepatitis B reactivation in patients receiving cancer chemotherapy.Factors associated with hepatic dysfunction in hepatitis B-positive patients with postgastrectomy adenocarcinoma.Patients with hematological malignancies and serological signs of prior resolved hepatitis B.Hepatitis B and inflammatory bowel disease: role of antiviral prophylaxisHepatitis B virus reactivation in HBsAg-negative, anti-HBc-positive patients receiving immunosuppressive therapy: a systematic review.
P2860
Q26752475-C0135FD4-3995-4AA9-8F64-616B6441F4E4Q27006996-03B83FDC-D7BA-4E3B-929C-A81264DCC49DQ33564294-B5D634DB-A9DA-4012-B9D3-2934DCD200CFQ33619636-ECD6F02A-96FD-4640-A755-D01987EF9E30Q33872813-DE423C5F-6861-4071-9FEE-2AFA2C759990Q34404991-8DD0E090-B31F-4BB0-84EB-66DCAE70F104Q34974883-C8631F81-147A-4163-BA46-97D8453E9DE0Q35051831-488C1F2F-A4E0-48E9-980C-AB5564CA6F30Q35095916-8CA6E904-6DC0-4F23-ADE9-E1D0D2620735Q35580212-3C1CC4B9-47B1-45FA-B5EC-B0EEA87416ABQ35746079-C463D709-13AE-4CE9-A080-0B3F7C793D35Q36001152-672D5A3A-EE39-41C9-B28F-67661A5904AAQ36121117-F2306522-05C1-4463-A83E-897E6EF41A1CQ36153966-7D394BA4-8894-4F91-8D3D-7FF6981E3F8BQ36167378-5C0FA555-8A84-43CF-A5E9-6C5616A8B976Q36220459-479F1517-07E0-4BF3-B655-02C588383FA0Q36225933-456DAEDB-B17A-4788-A6BE-69CB1EBD4B5BQ37999022-5887881D-277D-4095-ABDA-43C90CF06C2CQ38094015-488C905D-FC6E-42F3-A0FF-8D16B7CAF6B5Q55487854-63447E1E-C90A-4B11-B86C-B0BBAA4F5CC1
P2860
Hepatitis B virus reactivation and role of antiviral prophylaxis in lymphoma patients with past hepatitis B virus infection who are receiving chemoimmunotherapy.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Hepatitis B virus reactivation ...... receiving chemoimmunotherapy.
@en
Hepatitis B virus reactivation ...... receiving chemoimmunotherapy.
@nl
type
label
Hepatitis B virus reactivation ...... receiving chemoimmunotherapy.
@en
Hepatitis B virus reactivation ...... receiving chemoimmunotherapy.
@nl
prefLabel
Hepatitis B virus reactivation ...... receiving chemoimmunotherapy.
@en
Hepatitis B virus reactivation ...... receiving chemoimmunotherapy.
@nl
P2093
P356
P1433
P1476
Hepatitis B virus reactivation ...... receiving chemoimmunotherapy.
@en
P2093
Daniel S W Tan
Iain B Tan
Miriam Tao
Soon Thye Lim
Wan Cheng Chow
Yu Xuan Koo
P2860
P304
P356
10.1002/CNCR.24742
P407
P577
2010-01-01T00:00:00Z